Romo1 is associated with ROS production and cellular growth in human gliomas

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Romo1 is a mitochondrial protein whose elevated expression is commonly observed in various types of human cancers. However, the expression status of Romo1 and its implication in the pathogenesis of human glioblastoma (GBM) remain largely undefined. To understand the role of Romo1 in the progression of GBM, we explored its expression in a series of GBM tissues and cell lines and determined its effect on ROS production, cell proliferation, and tumor growth. Romo1 was frequently overexpressed at the mRNA level in both primary tumors and cell lines and its elevation was more commonly observed in high grade tumors versus low grade tumors. Romo1 expression was associated with ROS production and its knockdown led to a marked reduction of in vitro cellular growth and anchorage-independent growth of GBM. Consistently, Romo1 depletion induced a G2/M arrest of the cell cycle that was accompanied with accumulation of phospho-cdc2. Furthermore, a mouse xenograft assay revealed that Romo1 depletion significantly decreased tumor formation and growth. Therefore, our data demonstrate that Romo1 upregulation is a common event in human GBMs and contributes to the malignant tumor progression, suggesting that Romo1 could be a new therapeutic target for human GBM.

Original languageEnglish
Pages (from-to)73-81
Number of pages9
JournalJournal of Neuro-Oncology
Volume121
Issue number1
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Glioma
Glioblastoma
Growth
Neoplasms
G2 Phase Cell Cycle Checkpoints
Mitochondrial Proteins
Tumor Cell Line
Heterografts
Up-Regulation
Cell Proliferation
Cell Line
Messenger RNA

Keywords

  • Glioma
  • Reactive oxygen species
  • Romo1
  • Tumorigenicity

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neurology

Cite this

Romo1 is associated with ROS production and cellular growth in human gliomas. / Yu, Mi Ok; Song, Na Hyun; Park, Kyung-Jae; Park, Dong-Hyuk; Kim, Se Hyuk; Chae, Yang Seok; Chung, Yong Gu; Chi, Sung-Gil; Kang, Shin-Hyuk.

In: Journal of Neuro-Oncology, Vol. 121, No. 1, 01.01.2014, p. 73-81.

Research output: Contribution to journalArticle

@article{564be123583749c6b346812191b560ba,
title = "Romo1 is associated with ROS production and cellular growth in human gliomas",
abstract = "Romo1 is a mitochondrial protein whose elevated expression is commonly observed in various types of human cancers. However, the expression status of Romo1 and its implication in the pathogenesis of human glioblastoma (GBM) remain largely undefined. To understand the role of Romo1 in the progression of GBM, we explored its expression in a series of GBM tissues and cell lines and determined its effect on ROS production, cell proliferation, and tumor growth. Romo1 was frequently overexpressed at the mRNA level in both primary tumors and cell lines and its elevation was more commonly observed in high grade tumors versus low grade tumors. Romo1 expression was associated with ROS production and its knockdown led to a marked reduction of in vitro cellular growth and anchorage-independent growth of GBM. Consistently, Romo1 depletion induced a G2/M arrest of the cell cycle that was accompanied with accumulation of phospho-cdc2. Furthermore, a mouse xenograft assay revealed that Romo1 depletion significantly decreased tumor formation and growth. Therefore, our data demonstrate that Romo1 upregulation is a common event in human GBMs and contributes to the malignant tumor progression, suggesting that Romo1 could be a new therapeutic target for human GBM.",
keywords = "Glioma, Reactive oxygen species, Romo1, Tumorigenicity",
author = "Yu, {Mi Ok} and Song, {Na Hyun} and Kyung-Jae Park and Dong-Hyuk Park and Kim, {Se Hyuk} and Chae, {Yang Seok} and Chung, {Yong Gu} and Sung-Gil Chi and Shin-Hyuk Kang",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s11060-014-1608-x",
language = "English",
volume = "121",
pages = "73--81",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - Romo1 is associated with ROS production and cellular growth in human gliomas

AU - Yu, Mi Ok

AU - Song, Na Hyun

AU - Park, Kyung-Jae

AU - Park, Dong-Hyuk

AU - Kim, Se Hyuk

AU - Chae, Yang Seok

AU - Chung, Yong Gu

AU - Chi, Sung-Gil

AU - Kang, Shin-Hyuk

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Romo1 is a mitochondrial protein whose elevated expression is commonly observed in various types of human cancers. However, the expression status of Romo1 and its implication in the pathogenesis of human glioblastoma (GBM) remain largely undefined. To understand the role of Romo1 in the progression of GBM, we explored its expression in a series of GBM tissues and cell lines and determined its effect on ROS production, cell proliferation, and tumor growth. Romo1 was frequently overexpressed at the mRNA level in both primary tumors and cell lines and its elevation was more commonly observed in high grade tumors versus low grade tumors. Romo1 expression was associated with ROS production and its knockdown led to a marked reduction of in vitro cellular growth and anchorage-independent growth of GBM. Consistently, Romo1 depletion induced a G2/M arrest of the cell cycle that was accompanied with accumulation of phospho-cdc2. Furthermore, a mouse xenograft assay revealed that Romo1 depletion significantly decreased tumor formation and growth. Therefore, our data demonstrate that Romo1 upregulation is a common event in human GBMs and contributes to the malignant tumor progression, suggesting that Romo1 could be a new therapeutic target for human GBM.

AB - Romo1 is a mitochondrial protein whose elevated expression is commonly observed in various types of human cancers. However, the expression status of Romo1 and its implication in the pathogenesis of human glioblastoma (GBM) remain largely undefined. To understand the role of Romo1 in the progression of GBM, we explored its expression in a series of GBM tissues and cell lines and determined its effect on ROS production, cell proliferation, and tumor growth. Romo1 was frequently overexpressed at the mRNA level in both primary tumors and cell lines and its elevation was more commonly observed in high grade tumors versus low grade tumors. Romo1 expression was associated with ROS production and its knockdown led to a marked reduction of in vitro cellular growth and anchorage-independent growth of GBM. Consistently, Romo1 depletion induced a G2/M arrest of the cell cycle that was accompanied with accumulation of phospho-cdc2. Furthermore, a mouse xenograft assay revealed that Romo1 depletion significantly decreased tumor formation and growth. Therefore, our data demonstrate that Romo1 upregulation is a common event in human GBMs and contributes to the malignant tumor progression, suggesting that Romo1 could be a new therapeutic target for human GBM.

KW - Glioma

KW - Reactive oxygen species

KW - Romo1

KW - Tumorigenicity

UR - http://www.scopus.com/inward/record.url?scp=84921025311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921025311&partnerID=8YFLogxK

U2 - 10.1007/s11060-014-1608-x

DO - 10.1007/s11060-014-1608-x

M3 - Article

VL - 121

SP - 73

EP - 81

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 1

ER -